Silver Book Fact

In late stage Parkinson’s disease, as much as 80% of total costs of disease are due to indirect costs such as loss of income from patient and caregivers and poor quality of life.

Dowding, Clare H., Claire L. Shenton, and Sam S. Salek. A Review of the Health-Related Quality of Life and Economic Impact of Parkinson’s Disease. Drugs Aging. 2006; 23(9): 693-721. http://www.ncbi.nlm.nih.gov/pubmed/17020395

Reference

Title
A Review of the Health-Related Quality of Life and Economic Impact of Parkinson’s Disease
Publication
Drugs Aging
Publication Date
2006
Authors
Dowding, Clare H., Claire L. Shenton, and Sam S. Salek
Volume & Issue
Volume 23, Issue 9
Pages
693-721
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • In 2005, Medicare spent $91 billion caring for those with Alzheimer’s disease.  
  • Alzheimer’s disease is the most common neurodegenerative disease in the U.S.  
  • The lifetime risk at birth of developing Parkinson’s disease is around 2% for men and 1.3% for women.  
  • One study approximated that in 2002, employees who were caregivers of people with Alzheimer’s and other dementias cost U.S. businesses $36.5 billion.  
  • The number of Medicare claims for Alzheimer’s disease treatment grew by 250% during the 1990s, and is expected to increase by 300% over the next 10 years.